7-Methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine, 97%, 1g

2-Azetidinecarboxylic acid, 1-methyl-, (2S)-, 95.0%, 250mg

Ethyl 2-furoate, 95.0%, 100g

tert-butyl 2-methyl-3-{[2-(morpholin-4-yl)ethyl]amino}propanoate, 95.0%, 10g

6-chloro-1-(3-methylphenyl)-1-oxohexane, 97.0%, 5g

DBCO-CONH-S-S-NHS ester, 100mg

Dialysis systems Spectra/Por® Float-A-Lyzer® G2 Filling volume 10 ml, 8000–10000 dalton(s), 12 Piece(s)

3-Bromo-4-methoxytoluene, 99.0%, 1g

3-[[3,5-Bis(trifluoromethyl)phenyl]amino]-4-[(8α,9S)-cinchonan-9-ylamino]-3-cyclobutene-1,2-dione, 97%, 50mg

4-Bromo-3'-chlorobiphenyl, 97.0%, 25g

3-(p-Tolyl)propiolic Acid>98.0%(GC)(T)250mg

Brimonidine, 95%, 100mg

3-(Pyrrolidin-3-yl)propanoic acid hydrochloride, 95%, 500mg